We are excited to share that our co-founder and CEO, Kal Patel, MD, has been named by CEO Magazine as one of its “Top 20 Dynamic CEOs of 2020.” Read the feature here. The publication’s editors and judges assessed CEOs based on leadership ability, organizational revenue growth and successful management during challenging times over the past year.
The CEO Magazine selected Kal for his leadership in helping advance the adoption of digital health by the biopharma and medtech industry, using an innovative approach to support and optimize regulated drugs, devices, software and digital therapeutics. The judges also recognized his leadership in addressing current industry challenges and creating opportunities through engagement with other thought leaders.
The publication notes that “In just three years, BrightInsight has more than doubled its team, won contracts with several leading global pharmaceutical companies, and secured $65M in VC funding.”
Our approach is resonating with the industry and is evident in the adoption of our regulated BrightInsight Platform by the world’s top biopharma and medtech companies, including AstraZeneca, CSL Behring, Novo Nordisk and Roche. This had led to the creation of transformational digital health solutions on top of our security-, regulatory- and privacy-compliant infrastructure – faster and significantly less costly than it would have been without the BrightInsight platform.
As Kal is quoted in the profile as saying,
“We achieved these successes because of the tremendous talent of our employees, the trust of our clients and support from our investors—all of whom realize the tremendous opportunity BrightInsight has to be the de facto regulated digital health platform for biopharma and medtech.”
The BrightInsight team has helped create a company and platform we can all take pride in. This recognition comes soon after being named to the 2020 CB Insights Digital Health 150 and we look forward to sharing additional industry recognition as we close out a strong Q3.